Che-chuan Loong
Taipei, TNQ, Taiwan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 30 publications
Insufficient pretransplant induction therapy is associated with diffuse intrahepatic cholangiopathy in ABO-incompatible living donor liver transplantation for acute liver failure.
Journal: Journal of the Chinese Medical Association : JCMA
Published: January 22, 2025
A graft-to-recipient weight ratio of less than 0.7% under portal venous hemodynamics monitoring is a risk factor for early graft loss after living donor liver transplantation.
Journal: Surgery today
Published: January 14, 2025
Long-term outcomes of liver transplantation for alcohol-related liver disease.
Journal: Journal of the Chinese Medical Association : JCMA
Published: May 23, 2023
Arterial blood pressure waveform in liver transplant surgery possesses variability of morphology reflecting recipients' acuity and predicting short term outcomes.
Journal: Journal of clinical monitoring and computing
Published: May 05, 2023
Single-Center Experience in Managing Right Liver Grafts From Trifurcation or Independent Right Posterior Portal Vein in Adult Living Donor Liver Transplantation.
Journal: Transplantation proceedings
Published: March 18, 2023
Optimizing the Safe Washout Period for Liver Transplantation Following Immune Checkpoint Inhibitors with Atezolizumab, Nivolumab, or Pembrolizumab.
Journal: Transplantation proceedings
Published: March 15, 2023
The strategy of diminishing age gap effect on different donor-recipient combinations in living donor kidney transplantation.
Journal: Journal of the Chinese Medical Association : JCMA
Published: October 24, 2022
Repeated loco-regional therapies for hepatocellular carcinoma is associated with inferior outcome after living donor liver transplantation in cirrhotic patients.
Journal: Journal of the Chinese Medical Association : JCMA
Published: November 23, 2021
Drug-Drug Interactions With Cyclosporine in the Anti-Hepatitis C Viral PrOD Combination Regimen of Paritaprevir/Ritonavir-Ombitasvir and Dasabuvir in Organ Transplant Recipients With Severe Hepatic Fibrosis or Cirrhosis.
Journal: Therapeutic drug monitoring
Published: July 12, 2021
Living donor liver transplantation for small infants aged less than 6 months: The experience of a single institute.
Journal: Journal of pediatric surgery
Published: March 06, 2021
First-Pass Arrival Interval of Ultrasound Contrast Medium in the Hepatic Artery and Portal Vein as a Marker for Assessment of Liver Transplant Recipients.
Journal: Transplantation proceedings
Published: February 24, 2021
Safety and long-term outcomes of early liver transplantation for pediatric methylmalonic acidemia patients.
Journal: Pediatric transplantation
Published: January 07, 2021
Last Updated: 09/26/2026